Table 3 Laboratory characteristics of the HIV+ group
From: HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon
| Mean CD4 ± SE | P | Mean viral load ± SE | P | |
|---|---|---|---|---|
| (Cells/μl) [IQR] | (Log copies/ml) [IQR] | |||
| HIV+ Non-AIDS (N = 22) | 496 ± 51.5 | 2.86 ± 0.47 | ||
| [597.5 - 323] | [4.7 - 0.65] | |||
| 0.0005 | 0.1 | |||
| HIV+AIDS (N = 22) | 251 ± 38.9 | 4 ± 0.5 | ||
| [360.5 - 117] | [5.88 - 1.85] | |||
| HIV+ Non-AIDS | 493.4 ± 70.5 | 3.95 ± 0.38 | 0.0001 | |
| No ART (N = 16) | [620 - 268] | [5 - 2.78] | ||
| NS | ||||
| HIV+ Non-AIDS | 502.8 ± 47.6 | 0.33 ± 0.3 | ||
| ART (N = 6) | [620.5 - 375] | [0.98 - 0.0] | ||
| HIV+AIDS | 225.5 ± 42 | 5.12 ± 0.46 | ||
| No ART (N = 13) | 332.5 - 128] | NS | [6.1 - 4.84] | 0.0014 |
| HIV+AIDS | 292.5 ± 77.5 | 2.15 ± 0.67 | ||
| ART (N = 9) | [471.5 - 109] | [3.65 - 0.65] |